oleclumab
conatumumab
panitumumab
mapatumumab
drozitumab
patritumab
duligotuzumab
inotuzumab
naptumomab estafenatox
onartuzumab
lintuzumab
dacetuzumab
lexatumumab
matuzumab
tenatumomab
tigatuzumab
inotuzumab ozogamicin
figitumumab
dalotuzumab
pamrevlumab
nofetumomab
sibrotuzumab
acrixolimab
adecatumumab
lucatumumab
avelumab
pritumumab
iratumumab
teprotumumab
apolizumab
ramucirumab
volociximab
durvalumab
cixutumumab
agonistic monoclonal antibody
cergutuzumab
carlumab
ocrelizumab
sonepcizumab
tucotuzumab
samalizumab
cantuzumab
elotuzumab
alacizumab
glembatumumab
oportuzumab monatox
intetumumab
bivatuzumab
ipilimumab
tislelizumab